Nykode Therapeutics ASA
F:5VB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nykode Therapeutics ASA
F:5VB
|
NO |
|
Z
|
Zoetis Inc
XMUN:ZOE
|
US |
|
Kimball Electronics Inc
F:3C3
|
US |
|
Chariot Ltd
F:C62
|
UK |
|
E
|
Elanco Animal Health Inc
F:5EA
|
US |
|
Swiss Prime Site AG
OTC:SWPRF
|
CH |
|
A
|
Azenta Inc
F:BA3
|
US |
|
B
|
Braskem SA
BOVESPA:BRKM3
|
BR |
|
S
|
Sinotruk Hong Kong Ltd
XMUN:4SK
|
CN |
|
Energia Innovacion y Desarrollo Fotovoltaico SA
F:F63
|
ES |
|
C
|
Compagnie de Saint Gobain SA
XMUN:GOB
|
FR |
|
Samsung SDI Co Ltd
F:XSDG
|
KR |
|
I
|
Ipsos SA
XMUN:IPZ
|
FR |
|
Ipsos SA
F:IPZ
|
FR |
|
Ipsos SA
OTC:IPSOF
|
FR |
|
Lonza Group AG
SIX:LONN
|
CH |
|
Braskem SA
F:BRDA
|
BR |
|
A
|
Aurizon Holdings Ltd
XMUN:QRL
|
AU |
|
Algoma Central Corp
F:ACH
|
CA |
|
P
|
Premier Products PCL
SET:PPP
|
TH |
|
U
|
UAC Global PCL
SET:UAC
|
TH |
|
Advanced Micro Devices Inc
NASDAQ:AMD
|
US |
|
B
|
Braskem SA
BOVESPA:BRKM6
|
BR |
|
B
|
Braskem SA
SWB:BRDA
|
BR |
Bankruptcy Probability
Nykode Therapeutics ASA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Nykode Therapeutics ASA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NO |
N
|
Nykode Therapeutics ASA
OSE:NYKD
|
1.1B NOK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
481.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
182.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
127.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
78.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
45.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Nykode Therapeutics ASA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Nykode Therapeutics ASA has total debt of 1.3m USD. This includes both short-term (0 USD) and long-term (1.3m USD) debt.
You can find a full breakdown on its Balance Sheet.